QuantaLife, Inc. - A Bio-Rad Company

📍 Pleasanton, United States🗓 Founded 2008👥 29 employees💰 Last funded Jan 2011
Biotechnology Research🌐 bio-rad.com
Website LinkedIn
QuantaLife developed Droplet Digital(TM) PCR. Droplet Digital PCR provides an absolute measure of target molecules with unrivaled quantitative resolution and sensitivity. Applications include copy number variation (CNV), mutation detection, and gene expression analysis. Our mission is to provide tools that accelerate new strategies for the diagnosis and treatment of inherited disorders, cancer, and infectious disease. This technology is now a part of Bio-Rad Laboratories as the QX100 Droplet Digital PCR System. The original location of QuantaLife is now Bio-Rad's Digital Biology Center, where continual development of ddPCR technology is underway. Please follow the Bio-Rad Laboratories company page.
2
Total investors
1
Early stage
1
Mid stage
0
Late stage
2008
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in QuantaLife, Inc. - A Bio-Rad Company?
QuantaLife, Inc. - A Bio-Rad Company has 2 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did QuantaLife, Inc. - A Bio-Rad Company last raise funding?
The most recent investment in QuantaLife, Inc. - A Bio-Rad Company recorded on gritt.io was in January 2011.
When was QuantaLife, Inc. - A Bio-Rad Company founded?
QuantaLife, Inc. - A Bio-Rad Company was founded in 2008.
What industry is QuantaLife, Inc. - A Bio-Rad Company in?
QuantaLife, Inc. - A Bio-Rad Company operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is QuantaLife, Inc. - A Bio-Rad Company based?
QuantaLife, Inc. - A Bio-Rad Company is headquartered in Pleasanton, United States.